Cervical Orthosis Versus no Orthosis Following Multi-level Posterior Cervical Fusion
Primary Purpose
Posterior Cervical Spinal Surgery, Myelopathy Cervical, Radiculopathy, Cervical
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Cervical Orthosis (CO)
No Orthosis
Sponsored by
About this trial
This is an interventional treatment trial for Posterior Cervical Spinal Surgery
Eligibility Criteria
Inclusion Criteria:
- Undergoing multi-level (2- or more level), open, posterior cervical fusion which may extent into the second thoracic vertebrae (C1-T2)
- Able to consent to inclusion in the study
- 18 years of age and older
Exclusion Criteria:
- Spinal cord injury
- Primary cervical spine infection
- Cervical spine tumor
- Inability to comprehend patient rated outcome instruments
- Substance abuse
- Dementia
- Psychosis
- Previous surgery at same level
Sites / Locations
- London Health Sciences Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Cervical Orthosis (CO)
No Orthosis (NO)
Arm Description
Cervical orthosis will be worn at all times for 6 weeks according the standard of care after posterior cervical fusion
No cervical orthosis will be worn after posterior cervical fusion
Outcomes
Primary Outcome Measures
Neck pain intensity
numerical rating scale, 0 to 10 with higher scores indicating more severe pain
Secondary Outcome Measures
Neck Disability Index
NDI is a self-administered questionnaire with 10 questions. Each question is scored from 0 to 5 for a maximum score of 50 and the score converted to a percentage score. The scale ranges from 0 to 100 with a higher score denoting worse disability.
Arm pain intensity
numerical rating scale, 0 to 10 with higher scores indicating more severe pain
General health SF12
is a generic, multidimensional self-report health questionnaireQuestions are categorized into scales for general health, physical functioning, social functioning, role limitation-physical, role limitation-emotional, mental health, energy/fatigue, pain, comparative health. These are summarized into the SF12-physical component summary score (PCS) and mental component summary score (MCS). Scores range from 0 to 100 with higher scores impling better functioning.
Treatment satisfaction (% of patients satisfied)
Treatment satisfaction will be assessed by the following question: "Are you satisfied with the results of your spine surgery?" using a 5-category scale as follows: 1) extremely satisfied, 2) somewhat satisfied, 3) Neither satisfied nor dissatisfied, 4) somewhat dissatisfied, 5) extremely dissatisfied.
Time to meet discharge status (days)
measured as the number of days it takes to meet all discharge criteria including:
Ambulating safely and independently as assessed by the physiotherapist
Pain controlled with oral analgesics
Minimal wound drainage following drain removal
For the CO group only: proficient donning and doffing the CO as assessed by physiotherapy/occupation therapy
Adverse Events rate (%)
The Spinal Adverse Events Severity Grading System (SAVES) form will be used to capture intra-operative, peri-operative, and post-operative adverse events and serious adverse events.
Pain medication usage
The total dosage of opioids and NSAID for the hospital length of stay will be calculated. The type of medication used (over the counter, NSAID, muscle relaxant, narcotics, anti-depressant, neuroeleptic and other) will be indicated as not taken, as needed, and daily at week 2, 4, 6, and 12 after surgery.
Range of motion
Change in cobb angle in flexion-extension xrays and a goniometer to measure flexion-extension and rotation
Compliance with wearing the collar (collar group only)
Patients will be asked they used the collar as prescribed. If not, they will be asked if they wore the collar at all, and if yes for how many hours per day. Compliance will be defined as prescribed, irregular or aborted. Patients will be compliant if they wear the collar for> 20 hours per day.
Full Information
NCT ID
NCT04308122
First Posted
March 6, 2020
Last Updated
November 14, 2022
Sponsor
Dr. Christopher Bailey
1. Study Identification
Unique Protocol Identification Number
NCT04308122
Brief Title
Cervical Orthosis Versus no Orthosis Following Multi-level Posterior Cervical Fusion
Official Title
A Randomized Trial of Cervical Orthosis Versus no Orthosis Following Multi-level Posterior Cervical Fusion
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
October 1, 2020 (Actual)
Primary Completion Date
August 1, 2022 (Actual)
Study Completion Date
September 30, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Dr. Christopher Bailey
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Use of cervical orthosis after instrumented posterior cervical spinal surgery is still widely practiced even though modern fusion techniques likely do not require additional stabilization from an external orthosis. This is a single, centre randomized, non-blinded equivalence trial. Patients undergoing multi-level posterior cervical fusion will be randomized to cervical orthosis (CO group) or no orthosis (NO group). Immediately following surgery patients in the CO group will be fitted with a Philadelphia collar prior to being transferred to the recovery room. On the patient ward a physiotherapist will fit the patient with a Cervimax/Aspen/Miami J collar which will be worn at all times for 6 weeks according the standard of care. The NO group will have no specific precautions applied to their neck range of motion. Outcomes will be assessed prior to surgery, on the second day after surgery, and at 2, 4, 6 and 12 weeks after surgery. The primary outcome will be neck pain score on the numerical rating scale (ranging from 0-10 with higher scores indicating more severe pain) during the first 4 weeks after surgery with an equivalence margin of 2.0 points. Secondary outcomes will be neck disability, general health, treatment satisfaction, pain medication use, adverse events, neck range of motion, time meeting discharge status, and compliance in wearing the collar.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Posterior Cervical Spinal Surgery, Myelopathy Cervical, Radiculopathy, Cervical, Spinal Stenosis Cervical, Spondylosis, Cervical
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
64 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cervical Orthosis (CO)
Arm Type
Active Comparator
Arm Description
Cervical orthosis will be worn at all times for 6 weeks according the standard of care after posterior cervical fusion
Arm Title
No Orthosis (NO)
Arm Type
Experimental
Arm Description
No cervical orthosis will be worn after posterior cervical fusion
Intervention Type
Device
Intervention Name(s)
Cervical Orthosis (CO)
Intervention Description
Immediately following surgery patients in the CO group will be fitted with a Philadelphia collar prior to being transferred to the recovery room. On the patient ward a physiotherapist will fit the patient with a Cervimax/Aspen/Miami J collar which will be worn at all times for 6 weeks according the standard of care.
Intervention Type
Device
Intervention Name(s)
No Orthosis
Intervention Description
The NO group will have no specific precautions applied to their neck range of motion.
Primary Outcome Measure Information:
Title
Neck pain intensity
Description
numerical rating scale, 0 to 10 with higher scores indicating more severe pain
Time Frame
Through study duration to 12 weeks
Secondary Outcome Measure Information:
Title
Neck Disability Index
Description
NDI is a self-administered questionnaire with 10 questions. Each question is scored from 0 to 5 for a maximum score of 50 and the score converted to a percentage score. The scale ranges from 0 to 100 with a higher score denoting worse disability.
Time Frame
Through study duration to 12 weeks
Title
Arm pain intensity
Description
numerical rating scale, 0 to 10 with higher scores indicating more severe pain
Time Frame
Through study duration to 12 weeks
Title
General health SF12
Description
is a generic, multidimensional self-report health questionnaireQuestions are categorized into scales for general health, physical functioning, social functioning, role limitation-physical, role limitation-emotional, mental health, energy/fatigue, pain, comparative health. These are summarized into the SF12-physical component summary score (PCS) and mental component summary score (MCS). Scores range from 0 to 100 with higher scores impling better functioning.
Time Frame
Through study duration to 12 weeks
Title
Treatment satisfaction (% of patients satisfied)
Description
Treatment satisfaction will be assessed by the following question: "Are you satisfied with the results of your spine surgery?" using a 5-category scale as follows: 1) extremely satisfied, 2) somewhat satisfied, 3) Neither satisfied nor dissatisfied, 4) somewhat dissatisfied, 5) extremely dissatisfied.
Time Frame
Through study duration to 12 weeks
Title
Time to meet discharge status (days)
Description
measured as the number of days it takes to meet all discharge criteria including:
Ambulating safely and independently as assessed by the physiotherapist
Pain controlled with oral analgesics
Minimal wound drainage following drain removal
For the CO group only: proficient donning and doffing the CO as assessed by physiotherapy/occupation therapy
Time Frame
day 2
Title
Adverse Events rate (%)
Description
The Spinal Adverse Events Severity Grading System (SAVES) form will be used to capture intra-operative, peri-operative, and post-operative adverse events and serious adverse events.
Time Frame
Through study duration to 12 weeks
Title
Pain medication usage
Description
The total dosage of opioids and NSAID for the hospital length of stay will be calculated. The type of medication used (over the counter, NSAID, muscle relaxant, narcotics, anti-depressant, neuroeleptic and other) will be indicated as not taken, as needed, and daily at week 2, 4, 6, and 12 after surgery.
Time Frame
Through study duration to 12 weeks
Title
Range of motion
Description
Change in cobb angle in flexion-extension xrays and a goniometer to measure flexion-extension and rotation
Time Frame
Through study duration to 12 weeks
Title
Compliance with wearing the collar (collar group only)
Description
Patients will be asked they used the collar as prescribed. If not, they will be asked if they wore the collar at all, and if yes for how many hours per day. Compliance will be defined as prescribed, irregular or aborted. Patients will be compliant if they wear the collar for> 20 hours per day.
Time Frame
Through study duration to 12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Undergoing multi-level (2- or more level), open, posterior cervical fusion which may extent into the second thoracic vertebrae (C1-T2)
Able to consent to inclusion in the study
18 years of age and older
Exclusion Criteria:
Spinal cord injury
Primary cervical spine infection
Cervical spine tumor
Inability to comprehend patient rated outcome instruments
Substance abuse
Dementia
Psychosis
Previous surgery at same level
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chris Bailey
Organizational Affiliation
London Health Science Centre
Official's Role
Principal Investigator
Facility Information:
Facility Name
London Health Sciences Centre
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5W9
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Cervical Orthosis Versus no Orthosis Following Multi-level Posterior Cervical Fusion
We'll reach out to this number within 24 hrs